Full Press Release Details
Eisai to Host Annual Information Meeting with Update on LEQEMBI® (lecanemab-irmb).
BIIB
Eisai to Host Annual Information Meeting with Update on LEQEMBI® (lecanemab-irmb)
Key Takeaway: Eisai to Host Annual Information Meeting with Update on LEQEMBI® (lecanemab-irmb)
Price reaction · baseline $217.56 (2024-03-06 close) · hit after-hours · clean, no other BIIB news in the window
day 0 close
+0.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis